Estimating prion concentration in fluids and tissues by quantitative PMCA. - Wikidata - wikimedia - TriplyDB

Estimating prion concentration in fluids and tissues by quantitative PMCA.

Estimating prion concentration in fluids and tissues by quantitative PMCA.

http://www.wikidata.org/entity/Q33725459

about

An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy.Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification.Protein misfolding cyclic amplification of infectious prions.Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays Measuring cell-generated forces: a guide to the available tools Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.Lack of prion transmission by sexual or parental routes in experimentally infected hamsters Enriching libraries of high-aspect-ratio micro- or nanostructures by rapid, low-cost, benchtop nanofabrication.Prions in the urine of patients with variant Creutzfeldt-Jakob disease.Adhesion strength-based, label-free isolation of human pluripotent stem cells.Grass plants bind, retain, uptake, and transport infectious prions.Development of dose-response models of Creutzfeldt-Jakob disease infection in nonhuman primates for assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease Superparamagnetic nanoparticle capture of prions for amplification.Rapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone meals Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection Replication efficiency of soil-bound prions varies with soil type.Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.In vitro detection of prionemia in TSE-infected cervids and hamsters.An enzymatic treatment of soil-bound prions effectively inhibits replication.Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake.Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture Correlation between infectivity and disease associated prion protein in the nervous system and selected edible tissues of naturally affected scrapie sheep.Harnessing prions as test agents for the development of broad-range disinfectants Fast and ultrasensitive method for quantitating prion infectivity titre.Aryl Diazonium Chemistry for the Surface Functionalization of Glassy Biosensors Detection and Quantification of CWD Prions in Fixed Paraffin Embedded Tissues by Real-Time Quaking-Induced Conversion.Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases.Identification of misfolded proteins in body fluids for the diagnosis of prion diseases.Prions: Beyond a Single Protein.Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo.N-cadherin adhesive interactions modulate matrix mechanosensing and fate commitment of mesenchymal stem cells.Prion disease: experimental models and reality.Peripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters.Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche.Prion transmission: prion excretion and occurrence in the environment.Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo.Force transmission during adhesion-independent migration.Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease.

P2860

Q30784193-CCEA22D7-3D25-4DEC-A475-1D7FDB08F44C Q33646206-5826F83B-9D4A-4B9F-93EC-CE7A1C7F811E Q33725480-A80F64F0-E109-460B-9EA8-DE22CCEB37AE Q33769767-B63796BD-45DD-4A7F-B4C7-4190792B4427 Q33809070-B9840BC2-0AE3-475A-A946-B6A414B67112 Q33925227-4949E72F-D74C-45BF-9525-6C4107AA500F Q33967960-A086ADD5-A6C7-4C91-A712-880ED078BC38 Q34051195-C63510F9-7059-4230-9F4D-5F2683B26EB5 Q34142610-AFDBCE90-B930-4EEE-9C78-709A521FC042 Q34173236-CF0018A4-8700-408C-AAF7-438D5E1609A5 Q34337709-49026BE8-9180-4E69-BDCD-B527E8A56020 Q34476650-404EBA42-7DA4-42FC-A4F0-7909E5359909 Q34593983-8932A197-C467-4039-84D6-F8D411CFB139 Q34742787-6707CC83-182D-45EB-8038-D3C085C6DE8D Q34802813-EE890E55-0C52-482E-9839-12349263D3E7 Q34874108-37C1A287-B3D1-4A76-BBEB-05AD30A2C90D Q34982680-97B3DD65-C349-4212-9AB6-EA537327196D Q35036649-3A97D0A6-CFDC-4432-9671-75B8CA6DC987 Q35041621-52548E19-BC73-488A-9F23-E16EB44C3EC2 Q35080977-466E6901-5226-4F0D-897F-7DFB736934D7 Q35105375-00D0113F-FEDB-43AE-9E66-4E07D54E99A3 Q35146011-40235EDA-2828-4281-A3A6-0AFC2F12B57E Q35217464-C9C44B73-9351-4B6F-B103-5A8C920E8B8D Q35918919-C374C112-C195-4F1F-9A62-6332A35792DB Q36456289-9CB1CB0F-707D-4D97-8B22-C0C29761A173 Q36736021-F6F00548-7A16-48D0-9825-BF18B6E5D2F7 Q36881821-457F5882-B1A5-46B7-A49E-0CA0F8E1CF36 Q37085882-DF8EAF28-DF56-442F-AC96-96ED7A050071 Q37147766-BE13BB85-45BA-4E6E-BAE0-851FC983CB01 Q37162363-80128A2C-A606-4B65-9956-1EB9622EBF2A Q37215766-36C95A20-1F2E-4B3C-8708-6169D20DB2DA Q37433317-E62D3A19-1E34-4907-BDDB-704B2B1EBBF7 Q37596801-2D569A25-9C89-471E-A2AA-85FA6594B6FA Q37693704-DF7161B6-284D-40B4-8089-8FE7CC9BB87E Q37730775-1A205027-4D9F-45DC-A9D2-5CA848DAB428 Q37800332-DC55536A-5442-479F-BB20-19E206AEE284 Q38718288-5947B326-CD65-48A9-8D80-B3D62A600E39 Q38899453-73699DF1-3565-4E86-B105-5857D19CFCA2 Q39076670-8690EB0D-2937-404B-A923-4D5799374C9B Q40399825-9D4BAC2E-7583-4D50-BDD6-AE601A93A1F9

P2860

Estimating prion concentration in fluids and tissues by quantitative PMCA.

http://www.wikidata.org/entity/Q33725459

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@ast

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@en

type

label

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@ast

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@en

prefLabel

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@ast

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@en

P1433

Q33725459-DA925775-53D3-4668-8D77-9FA72A7886FE

P1476

Q33725459-7A7FEBFE-3EA1-4E52-B70C-452AB832BD5B

P2093

Q33725459-09774C23-E0E7-4F60-85F5-5ABCDA44353F

Q33725459-8C32C95A-09F1-44C9-9CDC-71FD656B1A3B

Q33725459-C2AFEEC3-8B79-4883-9C8F-FF4BBD9D83E6

Q33725459-D20F27F5-294E-41F3-A686-49E217AA2065

P2860

Q33725459-06E75947-3E70-4FB9-A0F3-A02C0FC2AD5C

Q33725459-0FED0B02-812B-43A1-B1A3-963BFC5B6B7A

Q33725459-221A428A-B60E-493A-A334-3BCDF6A9EA9F

Q33725459-22DAE4B0-F44F-4C1C-8ECD-2C6594462A0E

Q33725459-2BDB77FD-B101-4229-9851-0C853D074E34

Q33725459-2D618CB3-36E1-4A25-8529-DE95E5697B9D

Q33725459-5D0DFDDD-CFDA-4286-A8B1-745208B1917F

Q33725459-6A28F612-C17D-4554-8A48-373B880E9A8B

Q33725459-6FD66A52-B641-4FCD-9BE7-AF4283EF7E49

Q33725459-827032E3-4FDC-4850-B308-D5F0742B10FC

P2888

Q33725459-8793DA78-D02F-4ED4-8B7C-E7B38063874E

P304

Q33725459-6D39E103-A4E5-4212-ABBA-BE17C29BA14D

P31

Q33725459-A2CD5A6A-099F-41CF-BFA3-5428F8EA89E1

P356

Q33725459-9880B4F8-8F1C-4D64-B055-90F3FF902EA9

P433

Q33725459-EA6706A3-CF4A-4CCE-BECA-8ADC5EACA8ED

P478

Q33725459-82CE0F29-B998-4691-A15A-7A61A1BFC22B

P577

Q33725459-4C1289C3-C8EF-4D1B-A45F-80C9EA44A30F

P6179

Q33725459-F73531A4-1A9D-41DE-925D-4A268DAE991D

P698

Q33725459-B2766FDE-DB48-4587-8327-2551260975CE

P921

Q33725459-515CD187-B96F-4242-920C-36AA00135E65

P932

Q33725459-379F2A0D-4822-4F2E-A08D-78760B0891D0

P356

P1433

P1476

Estimating prion concentration in fluids and tissues by quantitative PMCA.

@en

P2093

Baian Chen

http://www.w3.org/2001/XMLSchema#string

Claudio Soto

http://www.w3.org/2001/XMLSchema#string

Marcelo A Barria

http://www.w3.org/2001/XMLSchema#string

Rodrigo Morales

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

In vitro generation of infectious scrapie prions.

Detection of prions in blood.

Diagnosing prion diseases: needs, challenges and hopes.

Protein misfolding cyclic amplification for diagnosis and prion propagation studies.

Reduction of prion infectivity in packed red blood cells.

Transmissible spongiform encephalopathy in the 21st century: neuroscience for the clinical neurologist.

Prions: protein aggregation and infectious diseases.

Detection of infectious prions in urine

Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification.

P2888

P304

519-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NMETH.1465

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025934968

http://www.w3.org/2001/XMLSchema#string

P698

20512142

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family

P932

4049222

http://www.w3.org/2001/XMLSchema#string